2019 中国指南：老年高血压的管理—英文版

2019 Chinese Guideline for the Management of Hypertension in the Elderly (Full English Version)

1. Full English Text (Direct Links)

• PMC Full Text (Free, Full PDF/HTML):
   
  https://pmc.ncbi.nlm.nih.gov/articles/PMC6431598/
• PubMed Entry (Citation + Links):
   
  https://pubmed.ncbi.nlm.nih.gov/30923539/PubMed
• Journal of Geriatric Cardiology Original PDF:
   
  https://pdfs.semanticscholar.org/0626/854b9603b57770c78520f7fb5af6ce31a5b8.pdf
• ResearchGate Full PDF:
   
  https://www.researchgate.net/publication/332714612_2019_Chinese_guideline_for_the_management_of_hypertension_in_the_elderly/fulltext/5fbcb12692851c933f51b439/2019-Chinese-guideline-for-the-management-of-hypertension-in-the-elderly.pdf

2. Basic Citation Information

• Title: 2019 Chinese guideline for the management of hypertension in the elderly
• Authors/Committees: Hypertension Branch of Chinese Geriatrics Society; National Clinical Research Center of the Geriatric Diseases–Chinese Alliance of Geriatric Cardiovascular Disease; Guideline Writing and Review Committee (Co-chairs: Qi Hua, Li Fan)
• Journal: Journal of Geriatric Cardiology
• Publication Date: February 2019
• Volume/Issue: 16(2): 67–99
• DOI: 10.11909/j.issn.1671-5411.2019.02.001
• PMID: 30923539; PMCID: PMC6431598PubMed

3. Core Scope & Key Content Highlights (English)

• Epidemiology & Burden: Hypertension prevalence >50% in adults ≥60 years, ~90% in those ≥80 years; low control rate (18.2% in 2015 vs. 7.6% in 2002).
• Diagnosis & BP Measurement: Office, home (HBPM), and ambulatory BP monitoring (ABPM); definitions of isolated systolic hypertension, white-coat, masked, and nocturnal hypertension.
• Stratified BP Targets by Age/Frailty:
  • ≥65 years: initial target <150/90 mmHg; if tolerated, <140/90 mmHg.
  • ≥80 years (robust): start at ≥150/90 mmHg, target <150/90 mmHg; may titrate to <140/90 mmHg if well-tolerated.
  • Frail elderly ≥80 years: start at ≥160/90 mmHg, target SBP <150 mmHg (avoid <130 mmHg).
   
• Pharmacologic Therapy:
  • Preferred first-line: low-dose thiazide diuretics, CCBs, ACEIs/ARBs.
  • ≥80 years/frail: low‑dose monotherapy as initial strategy (Class I, Level A).
  • Most others: initial low‑dose combination therapy (Class I, Level A).
  • Avoid dual RAS blockade (ACEI + ARB; Class III, Level A).
   
• Special Populations: Frail elderly, those with orthostatic hypotension, cognitive impairment, polypharmacy, and comorbidities (CAD, CKD, stroke, diabetes).
• Non-pharmacology: Salt restriction, physical activity, weight management, sleep, and psychosocial support.
• Community & Integrated Care: Primary care, home monitoring, and geriatric multidisciplinary management.

4. How to Download the Full English PDF

1. Go to the PMC link: https://pmc.ncbi.nlm.nih.gov/articles/PMC6431598/
2. On the right sidebar, click PDF (full text download).
3. Alternatively, use the Semantic Scholar or ResearchGate links above for direct PDF access.